Content is for educational purposes and does not constitute medical or legal advice. Clinical decisions remain the responsibility of the prescriber.
Compounded medications are specially prepared for individual patient needs based on a valid prescription and, as such, are not reviewed or approved by the FDA. Statements have not been evaluated by the FDA. Availability and permissible compounding practices vary by state law.
Striving for the Future of Compounding
Join Strive's advocacy leaders on the front lines of the fight to protect your patients' access to personalized medicine.
The decisions being made right now at the state and federal level will shape what personalized medicine looks like for your patients, and whether they can access it at all.
In this Strive Sessions webinar, our advocacy leaders will explain the current state of compounding policy, share how Strive represents patients and providers, and discuss key issues shaping the industry. You'll also hear how your experience as a provider can help policymakers better understand the real-world value of personalized medicine.
This webinar is designed for:
- Prescribing providers using compounded medications
- Clinic owners and healthcare leaders
- Pharmacists and other compounding professionals
- Providers interested in patient access and healthcare policy
- Clinical teams who want to show up for their patients beyond the exam room
In this session:
- Understand how state and federal policy can affect compounding, patient access, and provider choice
- Explore the legislative and regulatory issues currently shaping personalized medicine
- Discover how Strive works with policymakers and trade associations to represent patients and providers
- Learn how your firsthand experience as a provider can give policymakers a clearer picture of what's actually at stake
